menu_open Columnists
Rahul Sidhu

Rahul Sidhu

The Conversation

We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Early-onset Alzheimer’s: new drug shows promise in slowing the disease

Early-onset Alzheimer’s: new drug shows promise in slowing the disease

Around 5-10% of all Alzheimer’s cases are in people under the age of 65.

28.03.2025 10

The Conversation

Rahul Sidhu

Dementia: why prescription drugs like antibiotics and vaccines have been linked to lower risk of the disease

The researchers theorise the protective effects of these drugs could be because they reduce inflammation, control infections and improve overall brain...

04.02.2025 5

The Conversation

Rahul Sidhu

Alzheimer’s disease: toxic protein is turned bad by immune enzyme, mouse study shows

Alzheimer’s disease is one of the world’s biggest health problems. Yet, despite the fact millions of people globally are diagnosed with the disease...

26.11.2024 10

The Conversation

Rahul Sidhu

Alzheimer’s drug approved in the UK, but it won’t be available on the NHS – here’s why

The UK’s drugs regulator – the MHRA – has approved the Alzheimer’s drug donanemab, but it won’t be available on the NHS. The National Institute for...

28.10.2024 20

The Conversation

Rahul Sidhu

Why light pollution may be linked to greater risk of Alzheimer’s disease

Light pollution is a growing issue. Over the past 25 years, artificial lighting has surged by 49% worldwide. For perspective, the brightness of the...

18.09.2024 3

The Conversation

Rahul Sidhu

Nasal spray clears proteins linked to Alzheimer’s – new study

Scientists in America have developed a nasal spray that can remove proteins in the brain associated with Alzheimer’s disease – at least, in mice....

25.07.2024 1

The Conversation

Rahul Sidhu